Wilfred Ngwa develops technologies that integrate with radiation therapy to improve cancer treatment. He also chairs the Lancet Oncology commission on cancer in sub-Saharan Africa and advises the Biden Administration. He will be a professor of global health and radiation oncology.
During this week’s U.S.-Africa Leaders Summit, the White House’s Cancer Moonshot program highlighted several initiatives to drastically improve cancer outcomes in Africa. Two Botswana-Rutgers Partnership for Health efforts were featured.
The program, called Cancer Kitso, is being developed by the Botswana-Rutgers Partnership for Health to educate health care workers about cancer care and prevention. Pharmacists Joyce Kgatlwane and Jiyeon Joy Park discuss their involvement.
Herrera is a research scientist who studies epidemic viruses and infectious diseases, with a focus on developing diagnostic and therapeutic tools to improve disease outbreak preparedness and response. He is an assistant professor of global health at Rutgers Global Health Institute with joint appointments at Robert Wood Johnson Medical School.
When it comes to global health, there is no off season. This summer, Rutgers faculty, students, and staff have been involved in diverse projects that address health inequities, both in the U.S. and internationally.
Funded by Global Health Seed Grants, five faculty-led efforts will address disparities related to postpartum mental health, diseases of poverty, child feeding in farming communities, racial stigma in hospital care, and intimate partner violence.
On Rutgers Giving Day, a 24-hour fundraising event, Rutgers Global Health Institute raised $25,446 for the Botswana-Rutgers Partnership for Health.
Botswana Cancer Initiative Leader Discusses Parallels with AIDS and Progress on Oncology Workforce Training
Refeletswe Lebelonyane is a physician, public health professional, and program manager for the Botswana-Rutgers Partnership for Health. In this Q&A, she provides updates on cancer care and prevention efforts in Botswana and reflects on her past experiences confronting HIV/AIDS in the African country.
University experts in infectious disease, epidemiology, pediatrics, and global health share insights related to Omicron, which the World Health Organization has labeled a variant of concern.
In an interview for WRSU Rutgers Radio, institute director Richard Marlink offers perspective on the importance of a global response to COVID-19, vaccine infrastructure in Africa, vaccine production and safety, and the World Health Organization.